medigraphic.com
ISSN 2448-8909 (Print)

2023, Number 4

<< Back Next >>

Med Crit 2023; 37 (4)

PaO2/FiO2/PEEP ratio as a predictor of mortality in COVID-19 patients

Ramos EMS, Muñoz RMR

Language: Spanish
References: 11
Page: 342-347
PDF size: 219.27 Kb.


ABSTRACT

Introduction: there is an urgent need to identify prognostic factors, both clinical and paraclinical, that allow patient risk stratification and active control of COVID-19. In our setting, there have been no published studies evaluating the PaO2 /FiO2 /PEEP (P/F/PEEP) index as a predictor of mortality in COVID-19 patients. Objective: to determine if the PaO2/FiO2/PEEP index acts as a factor associated with mortality in COVID-19 patients. Material and methods: retrospective, analytical and cross-sectional study in patients diagnosed with severe COVID-19. Results: lower values were identified for the PaO2/FiO2 index among the cases that died: 143.23 ± 76.54 vs 162.79 ± 64.86 in the survivors, however, there was no significance (p = 0.263). In the PaO2/FiO2/PEEP index, the differences also decreased between the cases that died 140.27 ± 94.78 vs the survivors 191.25 ± 108.7 (p = 0.030). Conclusions: the PaO2/FiO2/PEEP index is a predictor of mortality in COVID-19 patients, it is significantly associated with an AUC higher than the PaO2/FiO2 index to predict mortality at a cut-off point of ≤ 80 as a mortality factor with a good specificity and high sensitivity.


REFERENCES

  1. Organización Mundial de la Salud. Estimación de la mortalidad de la COVID-19: nota científica. Organización Mundial de la Salud; 2020. Disponible en: https://apps.who.int/iris/handle/10665/333857

  2. Sayed M, Riaño D, Villar J. Novel criteria to classify ARDS severity using a machine learning approach. Crit Care. 2021;25(1):150.

  3. Palanidurai S, Phua J, Chan YH, Mukhopadhyay A. P/FP ratio: incorporation of PEEP into the PaO2/FiO2 ratio for prognostication and classification of acute respiratory distress syndrome. Ann Intensive Care. 2021;11(1):124.

  4. Bonanad C, García-Blas S, Tarazona-Santabalbina FJ, Díez-Villanueva P, Ayesta A, Sanchis Forés J, et al. Coronavirus: la emergencia geriátrica de 2020: documento conjunto de la Sección de Cardiología Geriátrica de la Sociedad Española de Cardiología y la Sociedad Española de Geriatría y Gerontología. Rev Esp Cardiol. 2020;73(7):569-576.

  5. AlGhatrif M, Cingolani O, Lakatta EG. The dilemma of coronavirus disease 2019, aging, and cardiovascular disease: insights from cardiovascular aging science. JAMA Cardiol. 2020;5(7):747-748.

  6. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-1062.

  7. Cao J, Tu WJ, Cheng W, Yu L, Liu YK, Hu X, et al. Clinical features and short-term outcomes of 102 patients with coronavirus disease 2019 in Wuhan, China. Clin Infect Dis. 2020;71(15):748-755.

  8. Trachsel D, McCrindle BW, Nakagawa S, Bohn D. Oxygenation index predicts outcome in children with acute hypoxemic respiratory failure. Am J Respir Crit Care Med. 2005;172(2):206-211.

  9. Kao HC, Lai TY, Hung HL, Chen YM, Chou PA, Wang CC, et al. Sequential oxygenation index and organ dysfunction assessment within the first 3 days of mechanical ventilation predict the outcome of adult patients with severe acute respiratory failure. ScientificWorldJournal. 2013;2013:413216.

  10. Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020;75(7):1730-1741.

  11. Braun J, Loyal L, Frentsch M, Wendisch D, Georg P, Kurth F, et al. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19. Nature. 2020;587(4):270-274.




2020     |     www.medigraphic.com